Henshaw Capital’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $957K | Hold |
3,224
| – | – | 0.04% | 116 |
|
|
2025
Q4 | $979K | Sell |
3,224
-1,023
| -24% | -$335K | 0.04% | 117 |
|
|
2025
Q3 | $1.45M | Buy |
4,247
+3,224
| +315% | +$979K | 0.05% | 98 |
|
|
2025
Q2 | $248K | Hold |
1,023
| – | – | 0.01% | 287 |
|
|
2025
Q1 | $278K | Buy |
+1,023
| New | +$239K | 0.01% | 280 |
|
|
2024
Q4 | – | Sell |
-1,023
| Closed | -$230K | – | 308 |
|
|
2024
Q3 | $230K | Sell |
1,023
-1,750
| -63% | -$315K | 0.01% | 297 |
|
|
2024
Q2 | $396K | Hold |
2,773
| – | – | 0.02% | 205 |
|
|
2024
Q1 | $434K | Buy |
2,773
+1,350
| +95% | +$217K | 0.02% | 194 |
|
|
2023
Q4 | $257K | Hold |
1,423
| – | – | 0.01% | 258 |
|
|
2023
Q3 | $256K | Sell |
1,423
-710
| -33% | -$140K | 0.01% | 249 |
|
|
2023
Q2 | $380K | Hold |
2,133
| – | – | 0.02% | 152 |
|
|
2023
Q1 | $460K | Hold |
2,133
| – | – | 0.03% | 131 |
|
|
2022
Q4 | $469K | Hold |
2,133
| – | – | 0.03% | 125 |
|
|
2022
Q3 | $288K | Hold |
2,133
| – | – | 0.02% | 209 |
|
|
2022
Q2 | $345K | Hold |
2,133
| – | – | 0.02% | 194 |
|
|
2022
Q1 | $402K | Hold |
2,133
| – | – | 0.02% | 192 |
|
|
2021
Q4 | $578K | Hold |
2,133
| – | – | 0.03% | 154 |
|
|
2021
Q3 | $774K | Hold |
2,133
| – | – | 0.05% | 128 |
|
|
2021
Q2 | $732K | Hold |
2,133
| – | – | 0.05% | 133 |
|
|
2021
Q1 | $742K | Hold |
2,133
| – | – | 0.05% | 130 |
|
|
2020
Q4 | $551K | Buy |
2,133
+382
| +22% | +$105K | 0.04% | 150 |
|
|
2020
Q3 | $502K | Hold |
1,751
| – | – | 0.04% | 151 |
|
|
2020
Q2 | $330K | Buy |
+1,751
| New | +$285K | 0.03% | 196 |
|
|
2020
Q1 | – | Sell |
-1,430
| Closed | -$237K | – | 324 |
|
|
2019
Q4 | $237K | Buy |
+1,430
| New | +$238K | 0.02% | 239 |
|
Other funds holding ONC
BBA
HA
